Detecting oral kallikrein-targeting therapy through triggered contact activation: A phase I study

J Allergy Clin Immunol. 2020 Dec;146(6):1446-1449.e5. doi: 10.1016/j.jaci.2020.03.038. Epub 2020 Apr 29.
No abstract available

Publication types

  • Clinical Trial, Phase I
  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Adult
  • Angioedemas, Hereditary* / blood
  • Angioedemas, Hereditary* / drug therapy
  • Bradykinin / blood*
  • Double-Blind Method
  • Humans
  • Kallikreins* / antagonists & inhibitors
  • Kallikreins* / blood
  • Male
  • Serine Proteinase Inhibitors / administration & dosage*
  • Serine Proteinase Inhibitors / adverse effects

Substances

  • Serine Proteinase Inhibitors
  • Kallikreins
  • Bradykinin